Patents by Inventor Roger Smith

Roger Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Power Distribution Monitoring System And Method
    Publication number: 20090240449
    Abstract: A power distribution monitoring system includes a number of power line mounted monitors. Each monitor can acquire data regarding the delivery of electrical power in the power line, wirelessly transmit and receive messages, and electromagnetically acquire and store operating electrical power from electrical current flowing in the power line. The system also includes an aggregator that can wirelessly transmit and receive messages and wirelessly output beacon messages. In response to beacon signals wirelessly output by the aggregator, each monitor co-acts with the aggregator to dynamically build a wireless communication network for the wireless communication of the data acquired by the monitor regarding the delivery of electrical power in the power line to the aggregator.
    Type: Application
    Filed: December 22, 2008
    Publication date: September 24, 2009
    Applicant: TOLLGRADE COMMUNICATIONS, INC.
    Inventors: Jeffrey A. Gibala, Regis J. Nero, Steven P. Day, Matthew G. Cimbala, Roger A. Smith
  • Local non-perturbative remote sensing devices and method for conducting diagnostic measurements of magnetic and electric fields of optically active mediums
    Publication number: 20090231583
    Abstract: Embodiments of the present invention are directed to pulsed polarimeters for conducting remote, non-perturbative diagnostic measurements of inducing fields of a medium demonstrating induced optical activity. In one aspect, a pulse polarimeter includes a light source emitting a polarized light pulse having sufficiently narrow spatial extent at a prescribed wavelength and a light gathering optical system including a light gathering optic having an optic axis directed toward the medium and positioned to collect and collimate a predetermined solid angle of an emission from the medium into a collimated emission beam, while preserving the polarization state of the emission.
    Type: Application
    Filed: April 25, 2008
    Publication date: September 17, 2009
    Inventor: Roger Smith
  • Preparation and Use of Aryl Alkyl Acid Derivatives for the Treatment of Obesity
    Publication number: 20090215780
    Abstract: This invention relates to certain aryl alkyl acid compounds, compositions, and methods for treating or preventing obesity and related diseases.
    Type: Application
    Filed: April 18, 2006
    Publication date: August 27, 2009
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: Roger Smith, Derek Lowe, Philip Coish, Ann-Marie Campbell, Gan Wang, Manoj Patel, Gerogiy Bondar
  • PREPARATION AND USE OF ARYL ALKYL ACID DERIVATIVES FOR THE TREATMENT OF OBESITY
    Publication number: 20090197795
    Abstract: This invention relates to certain aryl alkyl acid compounds, compositions, and methods for treating or preventing obesity and related diseases.
    Type: Application
    Filed: August 4, 2008
    Publication date: August 6, 2009
    Applicant: Bayer HealthCare LLC
    Inventors: Roger Smith, Ann-Marie Campbell, Philip Coish, Miao Dai, Susan Jenkins, Derek Lowe, Stephen O'Connor, Ning Su, Gan Wang, Mingbao Zhang, Lei Zhu
  • NOVEL PYRIMIDOTHIENOINDAZOLES
    Publication number: 20090186887
    Abstract: The invention relates to novel pyrimidothienoindazoles of formula (I) processes for their preparation and their use for preparing medicaments for the treatment or prophylaxis of disorders, especially of hyperproliferative disorders.
    Type: Application
    Filed: March 30, 2009
    Publication date: July 23, 2009
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: Chengzhi Zhang, Roger A. Smith, Gan Wang, Sharad K. Verma, Qingming Zhu
  • OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
    Publication number: 20090118268
    Abstract: This invention relates to the use of a group of aryl ureas in treating p38 mediated diseases, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: October 10, 2008
    Publication date: May 7, 2009
    Inventors: Bernd Riedl, Jacques Dumas, Uday Khire, Timothy B. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood, Mary-Katherine Monahan, Reina Natero, Joel Renick, Robert N. Sibley
  • Hydroxy, ?-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors
    Patent number: 7528255
    Abstract: The invention relates to the use of a group of aryl ureas in treating raf mediated diseases and pharmaceutical compositions for use in such therapy of the formula wherein, Y is NHR Hal is chlorine or bromine, R is H, CH3 or CH2OH, and X1 to X7 are each, independently, H, OH or —OC(O)C1-C4 alkyl, or a salt purified stereoisomer thereof, wherein at least one of X1 to X7 is OH or —OC(O)C1-C4 alkyl.
    Type: Grant
    Filed: February 11, 2002
    Date of Patent: May 5, 2009
    Assignee: Bayer Pharmaceuticals Corporation
    Inventors: Bernd Riedl, Jacques Dumas, Uday Khire, Timothy Lowinger, William Scott, Roger Smith, Jill Wood
  • Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
    Patent number: 7517880
    Abstract: This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases and proteolytic enzyme mediated diseases, and pharmaceutical compositions for use in such therapy.
    Type: Grant
    Filed: February 1, 2002
    Date of Patent: April 14, 2009
    Assignee: Bayer Pharmaceuticals Corporation
    Inventors: Scott Miller, Martin Osterhout, Jacques Dumas, Uday Khire, Timothy B. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood, David E. Gunn, Holia Hatoum-Mokdad, Marell Rodriguez, Robert Sibley, Ming Wang, Tiffany Turner, Catherine Brennan
  • INHIBITION OF P38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
    Publication number: 20090093526
    Abstract: This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases and proteolytic enzyme mediated diseases, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: October 31, 2007
    Publication date: April 9, 2009
    Inventors: Scott Miller, Martin Osterhout, Jacques Dumas, Uday Khire, Timothy B. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood, David E. Gunn, Holia Hatoum-Mokdad, Marell Rodriguez, Robert Sibley, Ming Wang, Tiffany Turner, Catherine Brennan
  • Pyrimidothienoindazoles
    Patent number: 7511048
    Abstract: The invention relates to novel pyrimidothienoindazoles of formula (I) processes for their preparation and their use for preparing medicaments for the treatment or prophylaxis of disorders, especially of hyperproliferative disorders.
    Type: Grant
    Filed: October 26, 2005
    Date of Patent: March 31, 2009
    Assignee: Bayer Pharmaceuticals Corporation
    Inventors: Chengzhi Zhang, Roger Smith, Gan Wang, Sharad Verma, Qingming Zhu
  • Local non-perturbative remote sensing devices and method for conducting diagnostic measurements of magnetic and electric fields of optically active mediums
    Publication number: 20090073442
    Abstract: Embodiments of the present invention are directed to pulsed polarimeters for conducting remote, non-perturbative diagnostic measurements of inducing fields of a medium demonstrating induced optical activity. In one aspect, a pulse polarimeter includes a light source emitting a polarized light pulse having sufficiently narrow spatial extent at a prescribed wavelength and a light gathering optical system including a light gathering optic having an optic axis directed toward the medium and positioned to collect and collimate a predetermined solid angle of an emission from the medium into a collimated emission beam, while preserving the polarization state of the emission.
    Type: Application
    Filed: September 14, 2007
    Publication date: March 19, 2009
    Inventor: Roger Smith
  • CRM SYSTEM AND METHOD HAVING DRILLDOWNS, ACLs, SHARED FOLDERS, A TRACKER AND A MODULE BUILDER
    Publication number: 20090070744
    Abstract: A business application system, such as a CRM system, is provided wherein the system include deeper chart drill-downs, access control lists, shared folders, a tracker module and/or a modular builder.
    Type: Application
    Filed: August 28, 2008
    Publication date: March 12, 2009
    Applicant: SugarCRM Inc.
    Inventors: Jacob Andrew Taylor, Majed Itani, Ajay Gupta, Andrew Wu, Joseph Parsons, Roger Smith, Chris Nojima
  • Aptamers utilized as targeting agents for pharmaceutical compounds used in the treatment of cancer and other diseases
    Publication number: 20090041837
    Abstract: This invention describes a method whereby selected aptamers are used as a carrier compound to deliver drug nanoparticles and/or drug liposomes to the tumor or disease site. These aptamers have the propensity to localize in areas of tissue necrosis. Many tumors have areas of necrosis that can be targeted using aptamer coated drug nanoparticles and/or aptamer coated drug liposomes. Similarly many infectious diseases and autoimmune diseases have areas of inflammation and/or areas of necrosis and can also be targeted using aptamer coated drug nanoparticles and/or aptamer coated drug liposomes.
    Type: Application
    Filed: August 4, 2008
    Publication date: February 12, 2009
    Inventors: Henry John Smith, James Roger Smith
  • Fault tolerant computer system
    Patent number: 7484032
    Abstract: A computing hardware and software device called a Meta Mentor Central Processing Unit. The Meta Mentor purpose is to control memory, input/output interfaces, defining the operating system, the scheduling processes and the parsing of individual threads to an array of slave Processing Units that are uniquely connected, thus creating a highly optimized computing core. In effect, the Meta Mentor tells the array of slave processors what to process by controlling all external and internal system input/output and individual processor scheduling.
    Type: Grant
    Filed: June 30, 2005
    Date of Patent: January 27, 2009
    Inventor: Roger A. Smith
  • Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
    Publication number: 20080300281
    Abstract: This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: July 28, 2008
    Publication date: December 4, 2008
    Inventors: Jacques Dumas, Uday Khire, Timothy B. Lowinger, Bernd Riedl, William J. Scott, Roger A. Smith, Jill E. Wood, Holia Hatoum-Mokdad, Jeffrey Johnson, Aniko Redman, Robert Sibley
  • METADATA DRIVEN USER INTERFACE SYSTEM AND METHOD
    Publication number: 20080276218
    Abstract: A metadata driven user interface system and method are provided. In an exemplary embodiment, a software-based customer relationship management system and method may include the metadata driven user interface system.
    Type: Application
    Filed: April 4, 2008
    Publication date: November 6, 2008
    Applicant: SugarCRM Inc.
    Inventors: Jacob Taylor, Majed Itani, Roger Smith
  • Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
    Publication number: 20080269265
    Abstract: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: June 25, 2008
    Publication date: October 30, 2008
    Inventors: Scott Miller, Martin Osterhout, Jacques Dumas, Uday Khire, Timothy B. Lowinger, Bernd Riedl, William J. Scott, Roger A. Smith, Jill E. Wood, David Gunn, Martha Rodriguez, Ming Wang, Tiffany Turner, Catherine Brennan
  • Remote testing of high speed data and voice communication networks
    Patent number: 7433323
    Abstract: Faults or degradation of performance of a voice/data communication network (2) are identified without the need to dispatch service personnel by selectively testing isolated sections of the communication network. For some of these tests, the communication network address of a customer's modem under test (106, 114, 60, 66) is retrieved from a database (88) for use in directing these tests to the customer's modem (106, 114, 60, 66) and for emulating the customer's modem (106, 114, 60, 66) during one or more of the tests.
    Type: Grant
    Filed: May 31, 2002
    Date of Patent: October 7, 2008
    Assignee: Tollgrade Communications, Inc.
    Inventor: Roger A. Smith
  • Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
    Patent number: 7423156
    Abstract: This invention relates to certain aryl alkyl acid compounds, compositions, and methods for treating or preventing obesity and related diseases.
    Type: Grant
    Filed: January 27, 2006
    Date of Patent: September 9, 2008
    Assignee: Bayer Pharmaceuticals Corporation
    Inventors: Roger Smith, Ann-Marie Campbell, Philip Coish, Miao Dai, Susan Jenkins, Derek Lowe, Stephen O'Connor, Ning Su, Gan Wang, Mingbao Zhang, Lei Zhu
  • Substituted Pyrazolyl Urea Derivatives Useful in the Treatment of Cancer
    Publication number: 20080214545
    Abstract: The present invention relates to compounds of formula (I), pharmaceutical compositions which contain them and methods for treating cancer using compounds of formula (I).
    Type: Application
    Filed: May 2, 2005
    Publication date: September 4, 2008
    Inventors: Wendy Lee, Gaetan Ladouceur, Jacques Dumas, Roger Smith, Shihong Ying, Gan Wang, Zhi Chen, Qingjie Liu, Holia Hatoum Mokdad